IR
Corestem is a biopharmaceutical company that researches and commercializes stem cell technology.
Disclosures
| No. | Presentation Obligator | Date | Pubilc Disclosure | Writer |
|---|---|---|---|---|
| 1 | (주)코아스템 | 2022.09.15 | [Revised]Resolutions for Convocation of General Meeting of Shareholders | |
| 2 | (주)코아스템 | 2022.09.15 | [Revised]Decision on Merger | |
| 3 | (주)코아스템 | 2022.09.06 | [Revised]Decision on Merger | |
| 4 | (주)코아스템 | 2022.09.05 | Additional Listing(국내사모 CB전환) | KOSDAQ STOCK MKT. |
| 5 | (주)코아스템 | 2022.08.23 | [Investment Caution]small number of accounts being focused on | |
| 6 | (주)코아스템 | 2022.08.16 | Resolutions for Convocation of General Meeting of Shareholders | |
| 7 | (주)코아스템 | 2022.08.16 | Suspension of Trading(합병) | KOSDAQ STOCK MKT. |
| 8 | (주)코아스템 | 2022.08.16 | Decision on Merger | |
| 9 | (주)코아스템 | 2022.08.08 | Material Management Information related to Judgment of Investment(근위축성측삭경화증(루게릭병) 환자를 대상으로 HypoThermosol® FRS (HTS-FRS)를 현탁화제로 혼합한 뉴로나타-알주(자가골수유래중간엽줄기세포)의 안전성 평가를 위한 제 1상 임상시험 계획(IND) 승인) | |
| 10 | (주)코아스템 | 2022.08.03 | [Investment Caution]Issue with sudden change in closing price |
-
2022.09.15
-
2022.09.15
-
2022.09.06
-
2022.09.05
-
2022.08.23
-
2022.08.16
-
2022.08.16
-
2022.08.16
-
2022.08.08
-
2022.08.03
- 24, Pangyo-ro 255beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea
- Gen (02) 497-3711
- IR DID 070-4706-3546
- FAX (02) 6349-8666
- E-MAIL corestem@corestem.com
Copyright 2018 CORESTEM, Inc All right reserved.
